| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |